Luke Lango’s Briefing Goes Live On Oct 6 

On Oct 6 at 1 PM ET, Luke Lango reveals a free pick that could soar as Trump’s Senate Bill 1582 triggers a $4 trillion explosion.

Mon, October 6 at 1:00PM ET
 
 
 
 
Register Here (FREE)
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Why Is Assertio (ASRT) Stock Down 46% Today?

By William White, InvestorPlace Writer
Assertio (ASRT) stock is falling hard on Friday after the pharmaceutical company released a mixed earnings report for Q2 2023!

7 Penny Stocks Nearing Super Attractive Entry Points

By Thomas Niel, InvestorPlace Contributor
Consider these 7 under-$5 per share stock prime penny stock opportunities, as each one has strong long-term upside potential.

3 AI Stocks Billionaires Are Loading Up On

By Larry Ramer, InvestorPlace Contributor
With investors pouring funds into AI, it makes sense to consider snapping up the top AI stocks billionaires buy.

5 Investors Betting on T2 Biosystems (TTOO) Stock Now

By Bret Kenwell, InvestorPlace Contributor
T2 Biosystems has been on fire this week since receiving a compliance extension from the Nasdaq. TTOO stock is up over 200% this week alone.

GSA Partners Is Betting Big on T2 Biosystems (TTOO) Stock

By Samuel O'Brient, InvestorPlace Reporter
GSA Capital Partners is upping its bet on T2 Biosystems. Here's what this news means for TTOO stock and its investors.

TTOO Stock Alert: Is T2 Biosystems the Next Meme Stock?

By Larry Ramer, InvestorPlace Contributor
TTOO stock is soaring for a second straight day. T2 Biosystems develops medical testing systems for hospitals.

Why Is Virax Biolabs (VRAX) Stock Up Today?

By William White, InvestorPlace Writer
Virax Biolabs (VRAX) stock is on the rise Thursday as investors react to the news on an extension from the Nasdaq Exchange.

Is a Giant Short Squeeze Brewing in Rite Aid (RAD) Stock?

By Dana Blankenhorn, InvestorPlace Contributor
RAD stock is the third this week to head into a bankruptcy short squeeze. This "supernova" represents the imminent death of a once proud name.

Buckle Up! 3 Healthcare Stocks Set to Soar to New Heights

By Bret Kenwell, InvestorPlace Contributor
Individual healthcare stocks have been trading really well, even as the sector is treading water. Here are three to know about now.

Why Is Vicarious Surgical (RBOT) Stock Down 41% Today?

By William White, InvestorPlace Writer
Vicarious Surgical (RBOT) stock is falling on Thursday after the surgical robot company revealed details of a public offering.

Why Is Aravive (ARAV) Stock Down 58% Today?

By William White, InvestorPlace Writer
Aravive (ARAV) stock is plummeting on Thursday morning following the release of negative results from a Phase 3 clinical trial.

Sell Alert: 3 Healthcare Stocks to Dump ASAP

By Larry Ramer, InvestorPlace Contributor
These healthcare stocks to dump now will continue to be weighed down by legal issues and/or slumping sales.

Get Out Now! 7 Stocks to Dump After Sorry Q2 Earnings

By Joel Baglole, InvestorPlace Contributor
Not every company has hit the ball out of the park with their Q2 print. Many companies have issued disappointing results and lowered their forward guidance, causing their share price to fall.

3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now

By Jeremy Flint, InvestorPlace Contributor
Biotech stocks can be a lucrative investment opportunity, these three biotech stocks to buy now are among analyst favorites.

Buy Alert: 3 Healthcare Stocks Nearing Super Attractive Entry Points

By Muslim Farooque, InvestorPlace Contributor
Explore the resilience of healthcare stocks that are demonstrating signs of recovery, with robust long-term growth potential ahead.

3 Cannabis Stocks That Have 10-Bagger Potential

By Faisal Humayun, InvestorPlace Contributor
These are the high potential cannabis stocks to buy for multibagger returns as they represent companies with strong fundamentals and a robust growth outlook.

Why Is Aptevo Therapeutics (APVO) Stock Down 33% Today?

By William White, InvestorPlace Writer
Aptevo Therapeutics (APVO) stock is sliding lower on Wednesday after the biotechnology company announced a public share offering.

Looking for a Bargain? 3 Stocks to Buy That Are Down 10% in 2023

By Jeremy Flint, InvestorPlace Contributor
Investors looking for bargain stock opportunities in a rapidly-rising market should consider these companies that haven't yet bounced back.

Looking for a Bargain? 7 Cannabis Stocks to Buy That Are Down 10% in 2023

By Muslim Farooque, InvestorPlace Contributor
These undervalued cannabis stocks could deliver big gains for long-term investors as several catalysts could spark a rally in the sector. 
Load More Articles